Current Pharmaceutical Design is a leading international, peer-reviewed journal dedicated to advancing scientific knowledge in the fields of pharmaceutical sciences and rational drug design. With a high publication frequency of roughly 46 issues per year, the journal provides a rapid and reliable outlet for comprehensive reviews, mini-reviews, and original research articles that reflect contemporary developments in pharmacology and medicinal chemistry. Its scope encompasses drug discovery strategies, medicinal chemistry techniques, pharmacological profiling of new compounds, identification and validation of therapeutic targets, and mechanisms underlying disease pathology. Each issue is often thematically organized around significant therapeutic areas, with contributions from experts worldwide, ensuring focused and relevant coverage. The journal is indexed in major scientific databases including MEDLINE/PubMed, Scopus, and Science Citation Index Expanded, supporting broad visibility of its content. Current Pharmaceutical Design serves as a valuable resource for academic researchers, industrial scientists, clinicians, and policymakers seeking in-depth insight into contemporary challenges and opportunities in drug design and development. Its interdisciplinary approach bridges chemistry, biology, pharmacology, and clinical application, helping translate molecular discoveries into therapeutic innovation.

Current Pharmaceutical Design (CPD) is :

International, Peer-Reviewed, Open Access, Refereed, This journal focuses on pharmacology, medicinal chemistry, rational drug design, It publishes timely in-depth reviews, mini-reviews, research articles from leading pharmaceutical researchers that address current topics in drug discovery , Online or Print, weekly Journal

UGC Approved, ISSN Approved: P-ISSN - 1381-6128, E-ISSN - 1873-4286, Established in - 1995, Impact Factor - 2.8

Not Provide Crossref DOI

Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE